National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2018

The Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination of persons aged 11-12 years to protect against certain diseases, including human papillomavirus (HPV)-associated cancers, meningococcal disease, and pertussis (1). A booster dose of quadrivalent meningococcal conjugate vaccine (MenACWY) is recommended at age 16 years, and serogroup B meningococcal vaccine (MenB) may be administered to persons aged 16-23 years (1). To estimate vaccination coverage among adolescents in the United States, CDC analyzed data from the 2018 National Immunization Survey-Teen (NIS-Teen) which included 18,700 adolescents aged 13-17 years.* During 2017-2018, coverage with ≥1 dose of HPV vaccine increased from 65.5% to 68.1%, and the percentage of adolescents up-to-date† with the HPV vaccine series increased from 48.6% to 51.1%, although the increases were only observed among males. Vaccination coverage increases were also observed for ≥1 MenACWY dose (from 85.1% to 86.6%) and ≥2 MenACWY doses (from 44.3% to 50.8%). Coverage with tetanus and reduced diphtheria toxoids and acellular pertussis vaccine (Tdap) remained stable at 89%. Disparities in coverage by metropolitan statistical area (MSA)§ and health insurance status identified in previous years persisted (2). Coverage with ≥1 dose of HPV vaccine was higher among adolescents whose parents reported receiving a provider recommendation; however, prevalence of parents reporting receiving a recommendation for adolescent HPV vaccination varied by state (range = 60%-91%). Supporting providers to give strong recommendations and effectively address parental concerns remains a priority, especially in states and rural areas where provider recommendations were less commonly reported.

• Publication year

  2019

• Venue

  MMWR. Morbidity and mortality weekly report

• Publication date

  2019-08-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.15585/mmwr.mm6833a2PMID 31437143PMCID 6705894
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2021

  2021cited by this paper
• National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2019

  2020cited by this paper
• Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National Survey.

  2019cited by this paper
• Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2019

  2019influential reference
• Human Papillomavirus–Attributable Cancers — United States, 2012–2016

  2019cited by this paper
• National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2017

  2018cited by this paper
• Parents Who Decline HPV Vaccination: Who Later Accepts and Why?

  2018cited by this paper
• Barriers and facilitators to HPV vaccination among rural Alabama adolescents and their caregivers.

  2018cited by this paper
• Trends in High-grade Cervical Lesions and Cervical Cancer Screening in 5 States, 2008–2015

  2018cited by this paper
• The Need to Optimize Adolescent Immunization

  2017cited by this paper
• Provider communication and HPV vaccination: The impact of recommendation quality.

  2016cited by this paper
• Awareness and knowledge of Human Papillomavirus (HPV), HPV‐related cancers, and HPV vaccines in an uninsured adult clinic population

  2016cited by this paper
• National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014

  2015cited by this paper

• Beyond the check-up: how well-child exams, pediatric specialists, and provider recommendations can close HPV vaccine gaps for Chinese American Teens

  2026cites this paper
• A WeChat-delivered Information-Motivation-Behavioral skills intervention to improve HPV vaccine acceptability among Chinese gay, bisexual, and other men who have sex with men.

  2026cites this paper
• Mapping the global research landscape on HPV vaccine hesitancy: a machine-learning based bibliometric analysis.

  2026cites this paper
• A Scoping Review of Influences on HPV Vaccine Uptake in the Rural US.

  2026cites this paper
• Clinical Use of Zinc in Treatment of Human Papillomavirus Cervical Infection and Viral Warts: A Systematic Review and Meta‐Analysis

  2025influential citation
• Relationship Between HPV Vaccine Hesitancy and Attitudes Towards Early Detection of Cervical Cancer in Women of Reproductive Age.

  2025cites this paper
• Invasive Meningococcal Disease in the Post-COVID World: Patterns of Disease Rebound

  2025influential citation
• Drivers of HPV vaccine hesitancy in New York and Florida.

  2025cites this paper
• HPV vaccination coverage among children and adolescents in Greece using national prescription data.

  2025cites this paper
• Epidemiology of Anal Cancer.

  2025cites this paper
• Improving HPV Vaccine Coverage in Tennessee: Addressing Barriers and Expanding Access for Mid-Adults

  2025influential citation
• Human papillomavirus knowledge among Indigenous women of the Northern Plains: Exploring psychosocial and cultural determinants

  2025cites this paper
• The influence of national origin cues in HPV vaccination advertising: An eye-tracking study of visual attention and vaccine perception using quantitative and qualitative analysis

  2025cites this paper
• Global Perspectives on HPV Vaccination: Achievements, Challenges, and Lessons from the Brazilian Experience

  2025cites this paper
• Effective strategies in human papillomavirus (HPV) vaccination interventions to increase uptake in rural, low socioeconomic, indigenous and migrant populations: A scoping review.

  2025cites this paper
• Gains vs losses in pay-for-performance: Stated preference evidence from a U.S. survey

  2025cites this paper
• Tıp Fakültesi Öğrencilerinin Human Papilloma Virüs Enfeksiyonu ve Aşısına Yönelik Bilgi, Tutum ve Davranışlarının Değerlendirilmesi

  2025cites this paper
• Association Between Human Papillomavirus Vaccination and the Risk of Hashimoto’s Thyroiditis: A Cross-Sectional Study

  2025cites this paper
• Relación entre la vacilación ante la vacuna contra el VPH y las actitudes hacia la detección temprana del cáncer de cuello uterino en mujeres en edad reproductiva

  2025cites this paper
• Beyond the Check-Up: How Well-Child Exams, Pediatric Specialists, and Provider Recommendations Can Close HPV Vaccine Gaps for Chinese American Teens

  2025cites this paper
• Rural-urban disparities in human papillomavirus vaccination: Findings from a cross-sectional survey of 13 southern US states, December 2019-January 2020.

  2025cites this paper
• Inequalities in the risk and prevention of invasive meningococcal disease in the United States – A systematic literature review

  2024cites this paper
• A Review of Human Papillomavirus Vaccination and Associated Ethical Concerns

  2024cites this paper
• Pediatric HPV vaccination: Provider recommendations matter among hesitant parents.

  2024cites this paper
• DS-Swin Transformer HRNet for remote sensing images

  2024cites this paper
• Is it ethical for immunisations against human papillomavirus to be mandatory in young people aged 12–13 years old?

  2024cites this paper
• Past, present, and future policy considerations regarding meningococcal vaccination in the United States

  2024cites this paper
• Quality Initiative to Increase Early Initiation and Series Completion of HPV Vaccine and its Impact on Health Disparities.

  2024cites this paper
• Identifying and supporting vaccine champions in pediatric primary care: a qualitative interview study.

  2024cites this paper
• Comparing Cervical Cancer Screening Strategies in an Incarcerated Population

  2024cites this paper
• Pandemic antecedents - Exploring predictivity and relationships between COVID-19 vaccine uptake and influenza, shingles, and HPV vaccination.

  2024cites this paper
• Dosimetric and toxicity comparison between Syed-Neblett and Fletcher-Suit-Delclos Tandem and Ovoid applicators in high dose rate cervix cancer brachytherapy.

  2024cites this paper
• Differences in Pertussis Incidence by Race and Ethnicity in the United States, 2010-2017.

  2024cites this paper
• Retrospective study of a pilot program focused on educating dental patients on human papillomavirus and vaccination in a hospital setting.

  2024cites this paper
• Boot Camp Translation using Community-Engaged messaging for adolescent Vaccination: A Cluster-Randomized trial.

  2024cites this paper
• HPV Vaccination Practices Among Medical Trainees in Pediatrics, Obstetrics and Gynecology, and Family Medicine

  2024cites this paper
• Identifying Healthcare Professionals With Lower Human Papillomavirus (HPV) Vaccine Recommendation Quality: A Systematic Review.

  2024cites this paper
• What do cervical cancer patients know, how do they learn, and who do they tell? A pilot study.

  2024cites this paper
• Pilot Randomized Controlled Trial of an Intervention to Promote Human Papillomavirus Vaccine Uptake Among Young Women Who Attend Subsidized Clinics.

  2024cites this paper
• Associations of geographic-based socioeconomic factors and HPV vaccination among male and female children in five US states

  2024cites this paper
• Barriers to HPV vaccine series completion among a predominantly hispanic border population: a mixed method evaluation

  2024influential citation
• High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003–2006 and 2015–2018

  2024cites this paper
• Knowledge of HPV vaccination and associated HNC and treatment decision-making among minority populations.

  2024cites this paper
• A feasibility study assessing knowledge, vaccine hesitancy, and completion rates of free HPV vaccination in low-income uninsured adults.

  2024cites this paper
• Contemporary provider perspectives on how to address HPV vaccine hesitancy in the US: A qualitative study

  2024cites this paper
• Geographic variation of HPV-associated cancer incidence in Kentucky using spatial scan statistics

  2024influential citation
• Regional differences in provider recommendation of HPV vaccines among 13-to-17 year old adolescents from 2019 to 2021.

  2024cites this paper
• Disparities in HPV Vaccination Among Adolescents by Health Care Facility Type.

  2024cites this paper
• Feasibility of an innovative medical dental integration program to provide overdue adolescent vaccinations in a federally qualified health center

  2024cites this paper
• HPV vaccine behaviors and intentions among a diverse sample of women aged 27-45 years: implications for shared clinical decision-making

  2024cites this paper
• "But then that's another barrier": A qualitative study of parent and provider perspectives on rural versus urban disparities in adolescent vaccination.

  2024cites this paper
• Dissonance between posts of health agencies and public comments regarding COVID-19 and vaccination on Facebook in Northern California

  2024cites this paper
• Assessment of human papillomavirus vaccination rates of adolescents in California, 2018–2019

  2023cites this paper
• Assessing Barriers to Human Papillomavirus (HPV) Vaccination in At-Risk Rural Communities of Western North Carolina, United States

  2023influential citation
• Primary Prevention of Cancer

  2023cites this paper
• A Multivariate Probit Regression of the Uptake of Adolescent Vaccines Among Racial/Ethnic Minority Adolescents Before and During the COVID-19 Pandemic.

  2023cites this paper
• Awareness, attitudes, and practices on meningococcal serogroup B vaccination in the United States among parents of older adolescents and among young adults

  2023cites this paper
• Human papillomavirus vaccination uptake in the Rio Grande Valley of Texas: Results from a pilot community‐based educational and school‐based vaccination program

  2023cites this paper
• Getting Human Papillomavirus Vaccination Back on Track: A National Survey

  2023cites this paper
• Acceptability and readiness to promote human papillomavirus vaccination at ages 9–10 years: a feasibility study among North Carolina clinics

  2023cites this paper
• A semi-Markov multistate cure model for estimating intervention effects in stepped wedge design trials

  2023cites this paper
• Exploring the Barriers and Facilitators Influencing Human Papillomavirus Vaccination Decisions Among South Asian and Chinese Mothers: a Qualitative Study

  2023cites this paper
• HPV Vaccination among College Students in the South: The Role of HPV Knowledge on Vaccine Initiation and Completion

  2023cites this paper
• Reasons patients cite to their health-care professional for not initiating or completing human papillomavirus vaccination

  2023cites this paper
• The prevalence of human papillomavirus vaccination among racial and ethnic minority adolescents during the COVID-19 pandemic

  2023cites this paper
• Trends in research related to vaccine and cancer prevention from 1992 to 2022: A 30-years bibliometric analysis

  2023cites this paper
• Novel HPV Associated Oropharyngeal Squamous Cell Carcinoma Surveillance DNA Assay Cost Analysis

  2023cites this paper
• Application of the theoretical domains framework to identify factors influencing catch-up HPV vaccinations among male college students in the United States: A review of evidence and recommendations.

  2023cites this paper
• Quality Improvement Project to Increase Human Papillomavirus Two-Dose Vaccine Series Completion by 13 Years in Pediatric Primary Care Clinics.

  2023cites this paper
• Promoting HPV Vaccination in People with HIV: Factors to Consider

  2023cites this paper
• AACC Guidance Document on Cervical Cancer Detection: Screening, Surveillance, and Diagnosis.

  2023cites this paper
• Pharmacy-based immunization in rural USA during the COVID-19 pandemic: A survey of community pharmacists from five southeastern states

  2023cites this paper
• Parent-reported Barriers and Parental Beliefs Associated with Intentions to Obtain HPV Vaccination for Children in a Primary care Patient Population in Minnesota, USA

  2023cites this paper
• Factors Affecting Completion of Human Papillomavirus Vaccination Series by Gender in a Predominantly Hispanic Border Town Community

  2023cites this paper
• Examining Health Promotion Theories, Limitations, and Lessons Learned for HPV Vaccination Interventions among College Students in the United States: A Systematic Literature Review

  2023cites this paper
• Factors associated with HPV vaccine acceptability and hesitancy among Black mothers with young daughters in the United States

  2023cites this paper
• Human Papilloma Virus (HPV) and the Current State of Oropharyngeal Cancer Prevention and Treatment

  2023cites this paper
• Descriptive epidemiology of age at HPV vaccination: Analysis using the 2020 NIS-Teen

  2023cites this paper
• Parental perceptions of the HPV vaccine for prevention of anogenital and oropharyngeal cancers

  2023cites this paper
• Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma

  2023cites this paper
• Awareness, perceptions, and acceptance of human papillomavirus vaccination among parents in Hong Kong.

  2023cites this paper
• The association between YouTube use and knowledge of human papillomavirus-related cancers

  2023cites this paper
• Adaptation and Formative Evaluation of Online Decision Support to Implement Evidence-Based Strategies to Increase HPV Vaccination Rates in Pediatric Clinics

  2023cites this paper
• Individual, systemic and state factors associated with provider recommendation of HPV vaccination: Findings from NIS-Teen, 2020

  2023cites this paper
• Getting Human Papillomavirus Vaccination Back on Track: A National Survey

  2023cites this paper
• Recommended Interventions to Improve Human Papillomavirus Vaccination Uptake among Adolescents: A Review of Quality Improvement Methodologies

  2023cites this paper
• Cervical Cancer Prevention Knowledge (Cckp-64) among Female Students in Novi Sad, Serbia during COVID-19 Pandemic

  2023cites this paper
• Acceptability and readiness to promote human papillomavirus vaccination at ages 9-10 years: A pilot study among rural North Carolina clinics

  2023cites this paper
• Framing of national HPV vaccine recommendations and willingness to recommend at ages 9-10

  2023cites this paper
• Parent-reported provider recommendation of HPV vaccination among minority adolescents before and during the COVID-19 pandemic: Findings from the National Immunization Survey-Teen, 2019–2021

  2023cites this paper
• Human Papillomavirus Vaccination Uptake in the Rio Grande Valley: Results from a Pilot Community-Based Educational and School-Based Vaccination Program and Its Expansion

  2023cites this paper
• Healthcare Provider’s Perceived Self-Efficacy in HPV Vaccination Hesitancy Counseling and HPV Vaccination Acceptance

  2023cites this paper
• A Pilot Study of a Screening Program for Human Papillomavirus–Related Squamous Intraepithelial Lesion and Malignancy in Gynecologic Oncology Patients

  2023cites this paper
• Cervical High-Grade Squamous Intraepithelial Lesion Burden and Standard of Care Treatment Effectiveness and Safety in the United States, 2008–2018: The EACH-WOMAN Project

  2023cites this paper
• Digital Health Interventions to Improve Adolescent HPV Vaccination: A Systematic Review

  2023cites this paper
• Cancer Prevention Begins in Middle School: The Personal Advantages of HPV Immunization in Males

  2023cites this paper
• Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis

  2023cites this paper
• Knowledge of human papillomavirus vaccination: A multi-institution, cross-sectional study of allopathic and osteopathic medical students

  2023cites this paper
• Impact of human papillomavirus vaccine on cervical cancer epidemic: Evidence from the surveillance, epidemiology, and end results program

  2023cites this paper
• An Update on Human Papillomavirus Vaccination in the United States

  2023cites this paper